NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Cue Biopharma (CUE) Technical (Analysis) Reports Cue Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Cue Biopharma (CUE)

Technical Analysis Report for USA stock CUE Cue Biopharma. Dated: 10 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock CUE Cue Biopharma then click here. or read Experts views on Cue Biopharma or Forecast & share price targets of Cue Biopharma

Cue Biopharma Opened at 0.49 and Closed at: 0.48, which is -2.08% of previous session's close. It moved within a range of 0.48 and 0.51
The session was a Bearish session with an average volume of 247200, which is -169.8% of previous session's volumes.

• The stock has fallen, and its short term trend is also negative and in a downtrend.

Support for tomorrow is 0.47 and resistance for tomorrow is 0.5
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 0.47, 0.46 resistance for tomorrow's hourly charts is 0.5, 0.52

10 Day SMA for Cue Biopharma (CUE) is 0.56 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Cue Biopharma (CUE) is 0.58 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Cue Biopharma (CUE) is 0.69 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 0.74 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Cue Biopharma is 0.77 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Cue Biopharma is at 0.58 and 200 DMA is at 0.77, while 50 DMA and 100 DMA are at 0.69 and 0.74 respectively

Cue Biopharma (CUE) moving average of 20 SMA is at 0.58 and 20 EMA is at 0.57

Cue Biopharma (CUE) moving average of 50 SMA is at 0.69 and 50 EMA is at 0.64

Cue Biopharma (CUE) moving average of 100 SMA is at 0.74 and 100 EMA is at 0.77

Cue Biopharma (CUE) moving average of 200 SMA is at 0.77 and 200 EMA is at 1.02

Steris Plc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Steris Plc, about 24.95% more returns!

Dr Reddy has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Dr Reddy, about 28.43% more returns!

Zynex Inc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Zynex Inc, about 6.74% more returns!

Sensus Healthcare has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Sensus Healthcare, about 15.32% more returns!

Siga Technologies has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Siga Technologies, about 29% more returns!

Radnet Inc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Radnet Inc, about 32.07% more returns!

Pulmatrix Inc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Pulmatrix Inc, about 9.3% more returns!

Medpace Holdings has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Medpace Holdings, about 22.19% more returns!

Seres Therapeutics has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Seres Therapeutics, about 34.42% more returns!

Iridex Corporation has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Iridex Corporation, about 27.31% more returns!

Harrow Health has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Harrow Health, about 58.99% more returns!

Eyegate Pharmaceuticals has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Eyegate Pharmaceuticals, about 28.08% more returns!

Ensign Group has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Ensign Group, about 24.91% more returns!

Dariohealth Corp has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Dariohealth Corp, about 36.1% more returns!

Caredx Inc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Caredx Inc, about 48.23% more returns!

Benitec Biopharma has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Benitec Biopharma, about 23.67% more returns!

Autolus Therapeutics has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Autolus Therapeutics, about 40.86% more returns!

Ardelyx Inc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Ardelyx Inc, about 26.05% more returns!

Cue Biopharma Technical analysis of indicators

Price action analysis of Cue Biopharma (CUE) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Cue Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Cue Biopharma in short term but the buy signal is initial and weak.

Cue Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Cue Biopharma in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Cue Biopharma is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 0.54 and Cue Biopharma CUE stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Cue Biopharma CUE stock. Volume based technical analysis of Cue Biopharma CUE stock is negative.

Cue Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock CUE Cue Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And CUE Experts View which covers a lot of information including buying and selling signals

CUE future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Cue Biopharma or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet